D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 20,877 357 World Ranking 11071 National Ranking 5807

Research.com Recognitions

Awards & Achievements

2015 - Fellow of the American Psychological Association (APA)

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Psychiatry
  • Substance abuse

Maxine L. Stitzer mainly investigates Methadone, Anesthesia, Substance abuse, Psychiatry and Abstinence. Her Methadone study focuses on Methadone maintenance in particular. Her Anesthesia study incorporates themes from Clinical trial, Buprenorphine, Opioid, Placebo and Dosing.

The various areas that Maxine L. Stitzer examines in her Substance abuse study include Biopsychosocial model, Psychopathology, Addiction and Contingency management. The Psychiatry study combines topics in areas such as Clinical psychology and Opiate. Her studies in Abstinence integrate themes in fields like Social psychology, Reinforcement, Randomized controlled trial and Nicotine.

Her most cited work include:

  • Clinical pharmacology of buprenorphine: Ceiling effects at high doses (592 citations)
  • Clinical pharmacology of buprenorphine: Ceiling effects at high doses (592 citations)
  • A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence (531 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Psychiatry, Substance abuse, Methadone, Anesthesia and Abstinence. Her research ties Clinical psychology and Psychiatry together. The study incorporates disciplines such as Clinical trial, Stimulant, Psychosocial, Reinforcement and Addiction in addition to Substance abuse.

Her Methadone study integrates concerns from other disciplines, such as Urinalysis, Heroin and Opiate. Her research investigates the link between Anesthesia and topics such as Opioid that cross with problems in Pharmacology. Her Abstinence research includes elements of Internal medicine, Randomized controlled trial, Nicotine and Ambulatory care.

She most often published in these fields:

  • Psychiatry (39.95%)
  • Substance abuse (28.04%)
  • Methadone (26.19%)

What were the highlights of her more recent work (between 2010-2021)?

  • Psychiatry (39.95%)
  • Substance abuse (28.04%)
  • Contingency management (18.52%)

In recent papers she was focusing on the following fields of study:

Maxine L. Stitzer mostly deals with Psychiatry, Substance abuse, Contingency management, Abstinence and Psychological intervention. Psychiatry connects with themes related to Buprenorphine in her study. Her Buprenorphine study is concerned with the field of Opioid as a whole.

Her work in Substance abuse tackles topics such as Clinical trial which are related to areas like Medical education and Cocaine dependence. Her studies deal with areas such as Applied psychology and Clinical psychology as well as Contingency management. Many of her research projects under Abstinence are closely connected to Demography with Demography, tying the diverse disciplines of science together.

Between 2010 and 2021, her most popular works were:

  • Randomized Trial of Reduced-Nicotine Standards for Cigarettes. (207 citations)
  • Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial (102 citations)
  • Effects of varenicline on abstinence and smoking reward following a programmed lapse. (81 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Substance abuse

Her primary areas of study are Psychiatry, Psychological intervention, Contingency management, Abstinence and Randomized controlled trial. Maxine L. Stitzer interconnects Opiate Substitution Treatment and Buprenorphine in the investigation of issues within Psychiatry. Maxine L. Stitzer combines subjects such as Clinical trial, Intervention, Family medicine, Substance abuse and Physical therapy with her study of Psychological intervention.

Her work carried out in the field of Contingency management brings together such families of science as Substance abuse treatment and Clinical psychology. Her work in the fields of Drug Abstinence overlaps with other areas such as Demography. Her Methadone study contributes to a more complete understanding of Anesthesia.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical pharmacology of buprenorphine: Ceiling effects at high doses

S. L. Walsh;K. L. Preston;M. L. Stitzer;E. J. Cone.
Clinical Pharmacology & Therapeutics (1994)

926 Citations

A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence

Rolley E. Johnson;Mary Ann Chutuape;Eric C. Strain;Sharon L. Walsh.
The New England Journal of Medicine (2000)

772 Citations

Moderate- Vs High-Dose Methadone in the Treatment of Opioid Dependence: A Randomized Trial

Eric C. Strain;George E. Bigelow;Ira A. Liebson;Maxine L. Stitzer.
JAMA (1999)

523 Citations

Effect of Prize-Based Incentives on Outcomes in Stimulant Abusers in Outpatient Psychosocial Treatment Programs: A National Drug Abuse Treatment Clinical Trials Network Study

Nancy M. Petry;Jessica M. Peirce;Maxine L. Stitzer;Jack Blaine.
Archives of General Psychiatry (2005)

457 Citations

THE AGENCY FOR HEALTH CARE POLICY AND RESEARCH SMOKING CESSATION CLINICAL PRACTICE GUIDELINE

Michael C. Fiore;David W. Wetter;William C. Bailey;Glen Bennett.
JAMA (1996)

437 Citations

Comparison of buprenorphine and methadone in the treatment of opioid dependence

Eric C. Strain;Maxine L. Stitzer;Ira A. Liebson;George E. Bigelow.
American Journal of Psychiatry (1994)

390 Citations

A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.

Warren K Bickel;Warren K Bickel;Maxine L Stitzer;Maxine L Stitzer;George E Bigelow;George E Bigelow;Ira A Liebson;Ira A Liebson.
Clinical Pharmacology & Therapeutics (1988)

370 Citations

Cognitive impairment in methadone maintenance patients

Miriam Z Mintzer;Maxine L Stitzer.
Drug and Alcohol Dependence (2002)

359 Citations

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Jessica M. Peirce;Nancy M. Petry;Maxine L. Stitzer;Jack Blaine.
Archives of General Psychiatry (2006)

339 Citations

Dose-response effects of methadone in the treatment of opioid dependence.

Eric C. Strain;Maxine L. Stitzer;Ira A. Liebson;George E. Bigelow.
Annals of Internal Medicine (1993)

335 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Maxine L. Stitzer

Stephen T. Higgins

Stephen T. Higgins

University of Vermont

Publications: 106

Nancy M. Petry

Nancy M. Petry

University of Connecticut

Publications: 99

Warren K. Bickel

Warren K. Bickel

Virginia Tech

Publications: 98

Dorothy K. Hatsukami

Dorothy K. Hatsukami

University of Minnesota

Publications: 84

Thomas R. Kosten

Thomas R. Kosten

Baylor College of Medicine

Publications: 69

Kenneth A. Perkins

Kenneth A. Perkins

University of Pittsburgh

Publications: 68

Walter Ling

Walter Ling

University of California, Los Angeles

Publications: 66

Robert K. Brooner

Robert K. Brooner

Johns Hopkins University School of Medicine

Publications: 60

Neal L. Benowitz

Neal L. Benowitz

University of California, San Francisco

Publications: 60

Kathleen M. Carroll

Kathleen M. Carroll

Yale University

Publications: 59

John M. Roll

John M. Roll

Washington State University

Publications: 58

Jennifer W. Tidey

Jennifer W. Tidey

Brown University

Publications: 58

Jack E. Henningfield

Jack E. Henningfield

Johns Hopkins University School of Medicine

Publications: 58

Kenzie L. Preston

Kenzie L. Preston

National Institute on Drug Abuse

Publications: 58

Edward V. Nunes

Edward V. Nunes

Columbia University

Publications: 55

Kevin E. O'Grady

Kevin E. O'Grady

University of Maryland, College Park

Publications: 51

Trending Scientists

Louis L. Whitcomb

Louis L. Whitcomb

Johns Hopkins University

Luca Trevisan

Luca Trevisan

Bocconi University

Tommy Svensson

Tommy Svensson

Chalmers University of Technology

Zhibo Li

Zhibo Li

Qingdao University of Science and Technology

Jun Zhou

Jun Zhou

Huazhong University of Science and Technology

David R. Thorburn

David R. Thorburn

Murdoch Children's Research Institute

Vishwanath R. Iyer

Vishwanath R. Iyer

The University of Texas at Austin

Rucheng Wang

Rucheng Wang

Nanjing University

Jennifer A. Kelly

Jennifer A. Kelly

Oklahoma Medical Research Foundation

Brooks D. Cash

Brooks D. Cash

The University of Texas Health Science Center at Houston

Casper H.J. van Eijck

Casper H.J. van Eijck

Erasmus University Rotterdam

Wataru Yasui

Wataru Yasui

Hiroshima University

Hugo J. Duivenvoorden

Hugo J. Duivenvoorden

Erasmus University Rotterdam

Sian Ellard

Sian Ellard

University of Exeter

Jennifer Roberts

Jennifer Roberts

University of Sheffield

Arthur P. Bochner

Arthur P. Bochner

University of South Florida

Something went wrong. Please try again later.